1
|
Elessa D, Grosjean V, Lozeron P, Harel S, Royer B, Forgeard N, Thèves F, Talbot A, Malphettes M, Bengoufa D, Kubis N, Arnulf B. Rituximab with alkylating agent in anti-myelin-associated glycoprotein neuropathy: A retrospective study of 26 cases. Br J Haematol 2024. [PMID: 38500363 DOI: 10.1111/bjh.19412] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2023] [Revised: 03/05/2024] [Accepted: 03/10/2024] [Indexed: 03/20/2024]
Affiliation(s)
- D Elessa
- Service d'Immuno-Hématologie, Assistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Paris, France
- Université Paris Cité, Paris, France
| | - V Grosjean
- Université Paris Cité, Paris, France
- Service de Physiologie Clinique-Explorations Fonctionnelles, Assistance Publique - Hôpitaux de Paris, Hôpital Lariboisière, Paris, France
| | - P Lozeron
- Université Paris Cité, Paris, France
- Service de Physiologie Clinique-Explorations Fonctionnelles, Assistance Publique - Hôpitaux de Paris, Hôpital Lariboisière, Paris, France
| | - S Harel
- Service d'Immuno-Hématologie, Assistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Paris, France
- Université Paris Cité, Paris, France
| | - B Royer
- Service d'Immuno-Hématologie, Assistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Paris, France
- Université Paris Cité, Paris, France
| | - N Forgeard
- Service d'Immuno-Hématologie, Assistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Paris, France
- Université Paris Cité, Paris, France
| | - F Thèves
- Service d'Immuno-Hématologie, Assistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Paris, France
- Université Paris Cité, Paris, France
| | - A Talbot
- Service d'Immuno-Hématologie, Assistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Paris, France
- Université Paris Cité, Paris, France
| | - M Malphettes
- Université Paris Cité, Paris, France
- Service d'Immuno-pathologie Clinique, Assistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Paris, France
| | - D Bengoufa
- Université Paris Cité, Paris, France
- Laboratoire d'Immunologie, Assistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Paris, France
| | - N Kubis
- Université Paris Cité, Paris, France
- Service de Physiologie Clinique-Explorations Fonctionnelles, Assistance Publique - Hôpitaux de Paris, Hôpital Lariboisière, Paris, France
| | - B Arnulf
- Service d'Immuno-Hématologie, Assistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Paris, France
- Université Paris Cité, Paris, France
| |
Collapse
|
2
|
Forgeard N, Elessa D, Carpinteiro A, Belhadj K, Minnema M, Roussel M, Huart A, Javaugue V, Pascal L, Royer B, Talbot A, Gounot R, Hegenbart U, Schonland S, Karlin L, Harel S, Kastritis E, Bridoux F, Jaccard A, Arnulf B. Teclistamab in relapsed or refractory AL amyloidosis: a multinational retrospective case series. Blood 2024; 143:734-737. [PMID: 38096365 DOI: 10.1182/blood.2023022937] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2023] [Accepted: 11/28/2023] [Indexed: 02/23/2024] Open
Affiliation(s)
- Nathalie Forgeard
- Department of Immuno-hematology, Hôpital St-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France
- Unité de Formation et de Recherche de Médecine, Université Paris Cité, Paris, France
| | - Dikélélé Elessa
- Department of Immuno-hematology, Hôpital St-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France
- Unité de Formation et de Recherche de Médecine, Université Paris Cité, Paris, France
| | - Alexander Carpinteiro
- Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
| | - Karim Belhadj
- Department of Hematology, Hôpital Mondor, Assistance Publique-Hôpitaux de Paris, Créteil, France
| | - Monique Minnema
- Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Murielle Roussel
- Hematology Unit and Amyloidosis Center, University Hospital Limoges, Limoges, France
| | - Antoine Huart
- Department of Nephrology and Organ Transplantation, University Hospital Toulouse, Toulouse, France
| | - Vincent Javaugue
- Department of Nephrology and Amyloidosis Center, University Hospital Poitiers, France
| | - Laurent Pascal
- Department of Hematology, Hôpital St-Vincent de Paul, Lille, France
| | - Bruno Royer
- Department of Immuno-hematology, Hôpital St-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Alexis Talbot
- Department of Immuno-hematology, Hôpital St-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France
- Unité de Formation et de Recherche de Médecine, Université Paris Cité, Paris, France
| | - Romain Gounot
- Department of Hematology, Hôpital Mondor, Assistance Publique-Hôpitaux de Paris, Créteil, France
| | - Ute Hegenbart
- Department of Internal Medicine V, Amyloidosis Center Heidelberg, University Hospital Heidelberg, Heidelberg, Germany
| | - Stefan Schonland
- Department of Internal Medicine V, Amyloidosis Center Heidelberg, University Hospital Heidelberg, Heidelberg, Germany
| | - Lionel Karlin
- Department of Hematology, University Hospital Lyon Sud, Pierre-Bénite, France
| | - Stéphanie Harel
- Department of Immuno-hematology, Hôpital St-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Efstathios Kastritis
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Zografou, Greece
| | - Frank Bridoux
- Department of Nephrology and Amyloidosis Center, University Hospital Poitiers, France
| | - Arnaud Jaccard
- Hematology Unit and Amyloidosis Center, University Hospital Limoges, Limoges, France
| | - Bertrand Arnulf
- Department of Immuno-hematology, Hôpital St-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France
- Unité de Formation et de Recherche de Médecine, Université Paris Cité, Paris, France
| |
Collapse
|
3
|
Kumar S, Fonseca VR, Ribeiro F, Basto AP, Água-Doce A, Monteiro M, Elessa D, Miragaia RJ, Gomes T, Piaggio E, Segura E, Gama-Carvalho M, Teichmann SA, Graca L. Developmental bifurcation of human T follicular regulatory cells. Sci Immunol 2021; 6:6/59/eabd8411. [PMID: 34049865 DOI: 10.1126/sciimmunol.abd8411] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2020] [Revised: 02/22/2021] [Accepted: 04/29/2021] [Indexed: 12/20/2022]
Abstract
Germinal centers (GCs) are anatomic structures where B cells undergo affinity maturation, leading to production of high-affinity antibodies. The balance between T follicular helper (TFH) and regulatory (TFR) cells is critical for adequate control of GC responses. The study of human TFH and TFR cell development has been hampered because of the lack of in vitro assays reproducing in vivo biology, along with difficult access to healthy human lymphoid tissues. We used a single-cell transcriptomics approach to study the maturation of TFH and TFR cells isolated from human blood, iliac lymph nodes (LNs), and tonsils. As independent tissues have distinct proportions of follicular T cells in different maturation states, we leveraged the heterogeneity to reconstruct the maturation trajectory for human TFH and TFR cells. We found that the dominant maturation of TFR cells follows a bifurcated trajectory from precursor Treg cells, with one arm of the bifurcation leading to blood TFR cells and the other leading to the most mature GC TFR cells. Overall, our data provide a comprehensive resource for the transcriptomics of different follicular T cell populations and their dynamic relationship across different tissues.
Collapse
Affiliation(s)
- Saumya Kumar
- Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.,Instituto Gulbenkian de Ciência, Oeiras, Portugal
| | - Válter R Fonseca
- Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.,Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal
| | - Filipa Ribeiro
- Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.,Instituto Gulbenkian de Ciência, Oeiras, Portugal
| | - Afonso P Basto
- Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.,Instituto Gulbenkian de Ciência, Oeiras, Portugal
| | - Ana Água-Doce
- Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.,Instituto Gulbenkian de Ciência, Oeiras, Portugal
| | | | - Dikélélé Elessa
- Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal
| | - Ricardo J Miragaia
- Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK
| | - Tomás Gomes
- Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK
| | - Eliane Piaggio
- Institut Curie, PSL Research University, INSERM U932, Paris F-75005, France.,Centre d'Investigation Clinique Biotherapie CICBT 1428, Institut Curie, Paris F-75005, France
| | - Elodie Segura
- Institut Curie, PSL Research University, INSERM U932, Paris F-75005, France
| | - Margarida Gama-Carvalho
- BioISI - Biosystems and Integrative Sciences Institute, Faculty of Sciences, University of Lisbon, Lisboa 1749-016, Portugal
| | - Sarah A Teichmann
- Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.,Theory of Condensed Matter Group, Cavendish Laboratory/Department of Physics, University of Cambridge, JJ Thomson Ave., Cambridge CB3 0HE, UK
| | - Luis Graca
- Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal. .,Instituto Gulbenkian de Ciência, Oeiras, Portugal
| |
Collapse
|
4
|
Elessa D, Talbot A, Lombion N, Harel S, Galicier L, Veyradier A, Joly B, Andreoli A, Rigaudeau S, Azoulay É, Coppo P, Royer B, Arnulf B. Development of thrombotic thrombocytopenic purpura during lenalidomide therapy: three new cases and review of literature. Br J Haematol 2019; 188:338-340. [DOI: 10.1111/bjh.16333] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Affiliation(s)
- Dikélélé Elessa
- Department of Immunohematology Hôpital Saint‐Louis Assistance Publique – Hôpitaux de Paris ParisFrance
- University Paris Diderot Sorbonne Paris Cité Paris France
| | - Alexis Talbot
- Department of Immunohematology Hôpital Saint‐Louis Assistance Publique – Hôpitaux de Paris ParisFrance
- University Paris Diderot Sorbonne Paris Cité Paris France
| | - Naëlle Lombion
- Department of Immunohematology Hôpital Saint‐Louis Assistance Publique – Hôpitaux de Paris ParisFrance
- University Paris Diderot Sorbonne Paris Cité Paris France
| | - Stéphanie Harel
- Department of Immunohematology Hôpital Saint‐Louis Assistance Publique – Hôpitaux de Paris ParisFrance
- University Paris Diderot Sorbonne Paris Cité Paris France
| | - Lionel Galicier
- University Paris Diderot Sorbonne Paris Cité Paris France
- Department of Clinical Immunology Hôpital Saint‐Louis Assistance Publique – Hôpitaux de Paris Paris France
| | - Agnès Veyradier
- University Paris Diderot Sorbonne Paris Cité Paris France
- National Reference Center for Thrombotic Microangiopathy Hôpital Saint‐Antoine Assistance Publique ‒ Hôpitaux de Paris Paris France
- Department of Biological Hematology Hôpital Lariboisière Assistance Publique ‒ Hôpitaux de Paris Paris France
| | - Bérangère Joly
- University Paris Diderot Sorbonne Paris Cité Paris France
- National Reference Center for Thrombotic Microangiopathy Hôpital Saint‐Antoine Assistance Publique ‒ Hôpitaux de Paris Paris France
- Department of Biological Hematology Hôpital Lariboisière Assistance Publique ‒ Hôpitaux de Paris Paris France
| | - Annalisa Andreoli
- Department of Clinical Hematology Centre Hospitalier Victor Dupouy Argenteuil France
| | - Sophie Rigaudeau
- Department of Clinical Hematology Centre Hospitalier Versailles Le Chesnay France
| | - Élie Azoulay
- University Paris Diderot Sorbonne Paris Cité Paris France
- Department of Intensive Care Medicine Hôpital Saint‐Louis Assistance Publique – Hôpitaux de Paris Paris France
| | - Paul Coppo
- National Reference Center for Thrombotic Microangiopathy Hôpital Saint‐Antoine Assistance Publique ‒ Hôpitaux de Paris Paris France
- Department of Clinical Hematology Hôpital Saint Antoine Assistance Publique ‒ Hôpitaux de Paris Paris France
| | - Bruno Royer
- Department of Immunohematology Hôpital Saint‐Louis Assistance Publique – Hôpitaux de Paris ParisFrance
- University Paris Diderot Sorbonne Paris Cité Paris France
| | - Bertrand Arnulf
- Department of Immunohematology Hôpital Saint‐Louis Assistance Publique – Hôpitaux de Paris ParisFrance
- University Paris Diderot Sorbonne Paris Cité Paris France
| |
Collapse
|